PRESS RELEASE published on 04/15/2024 at 08:00, 1 year 7 months ago Ondine Biomedical Inc. Announces 32% Fewer SSIs After Steriwave Replaced Mupirocin Study at Mazankowski Alberta Heart Institute shows 32% reduction in cardiac infections with Steriwave replacing antibiotic standard. Significant cost savings and high compliance. Expert commentary available Steriwave Cost Savings Mazankowski Alberta Heart Institute Cardiac Infections Antimicrobial Treatment
BRIEF published on 04/10/2024 at 08:05, 1 year 7 months ago Ondine Biomedical Inc.'s Steriwave Cleared for Use in HCA Healthcare UK Facilities Antimicrobial Resistance Steriwave Healthcare-associated Infections HCA Healthcare UK Antibiotic Reduction
BRIEF published on 04/10/2024 at 08:05, 1 year 7 months ago Steriwave d'Ondine Biomedical Inc. autorisé à être utilisé dans les établissements HCA Healthcare au Royaume-Uni Steriwave Infections Nosocomiales Résistance Aux Antimicrobiens HCA Healthcare Royaume-Uni Réduction Des Antibiotiques
PRESS RELEASE published on 04/10/2024 at 08:00, 1 year 7 months ago Ondine Biomedical Inc. Announces Steriwave Authorized for use by HCA UK HCA UK authorizes Steriwave antimicrobial by Ondine Biomedical to combat healthcare-associated infections without inducing antimicrobial resistance. Approval allows wider adoption in healthcare facilities Antimicrobial Resistance Healthcare Facilities Steriwave Ondine Biomedical HCA UK
BRIEF published on 04/04/2024 at 08:05, 1 year 8 months ago Ondine Biomedical Inc. Expands into ICU Market with Steriwave® Antimicrobial Resistance Steriwave Ondine Biomedical Healthcare-associated Infections Intensive Care Unit
BRIEF published on 04/04/2024 at 08:05, 1 year 8 months ago Ondine Biomedical Inc. se développe sur le marché des soins intensifs avec Steriwave® Steriwave Ondine Biomedical Infections Nosocomiales Résistance Aux Antimicrobiens Unité De Soins Intensifs
PRESS RELEASE published on 04/04/2024 at 08:00, 1 year 8 months ago Ondine Biomedical Inc. Announces Entry into ICU Market Expands Revenue Potential Ondine Biomedical plans entry into ICU market following interest from Canadian Hospitals. The move aims to reduce infections with Steriwave® treatment without triggering antimicrobial resistance. Cost savings for hospitals expected Antimicrobial Resistance Ondine Biomedical ICU Market Steriwave® Hospital Infections
BRIEF published on 03/25/2024 at 08:05, 1 year 8 months ago Ondine Biomedical Inc. Achieves Commercial Adoption of Steriwave in NHS Hospitals Antimicrobial Resistance Ondine Biomedical Inc. Steriwave Surgical Site Infections NHS
BRIEF published on 03/25/2024 at 08:05, 1 year 8 months ago Ondine Biomedical Inc. parvient à l'adoption commerciale de Steriwave dans les hôpitaux du NHS Steriwave Infections Du Site Opératoire NHS Ondine Biomédicale Inc. Résistance Aux Antimicrobiens
PRESS RELEASE published on 03/25/2024 at 08:00, 1 year 8 months ago Ondine Biomedical Inc. Announces First commercial adoption of Steriwave by the NHS NHS hospitals adopt groundbreaking light-activated antimicrobial, Steriwave, to combat AMR and reduce surgical infections. Ondine Biomedical partners with NHS for further adoption Steriwave Ondine Biomedical NHS Hospitals Light-activated Antimicrobial Surgical Infections
Published on 12/05/2025 at 02:35, 9 hours 37 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 11 hours 12 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 13 hours 7 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 13 hours 12 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 12:05, 7 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 12 minutes ago CGTN:Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 12 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 11:08, 1 hour 3 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 12/05/2025 at 08:45, 3 hours 27 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 3 hours 27 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 3 hours 30 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 17 hours 57 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 18 hours 12 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025